| scholarly article | Q13442814 |
| P2093 | author name string | Michael Linden | |
| Brian Van Ness | |||
| Nicole Kirchhof | |||
| Cathy Carlson | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 2779-2786 | |
| P577 | publication date | 2003-12-04 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies. | |
| P478 | volume | 103 |
| Q45885513 | 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity |
| Q30561836 | (18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib. |
| Q40140803 | ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells. |
| Q35055356 | Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia |
| Q36238764 | Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies |
| Q33930178 | Apoptosis of multiple myeloma. |
| Q37197900 | BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice |
| Q33412343 | Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL. |
| Q50640068 | Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. |
| Q39742944 | Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis |
| Q42575292 | Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform |
| Q92740937 | Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cells |
| Q55038802 | Mouse models of multiple myeloma: technologic platforms and perspectives. |
| Q34380431 | Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice |
| Q36892623 | Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death. |
| Q34047859 | Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained |
| Q37523208 | R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells. |
| Q41121076 | Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia |
| Q60916539 | Targeting the Bcl-2 Family in B Cell Lymphoma |
| Q27010154 | The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics |
| Q37854419 | The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy |
Search more.